New Medicine for Drug resistant TB patients

The regular medicines are given for 9 to 24 months. However, Bedaquiline is given only for 9 to 12 months.

116
TB Programme

Last Updated on August 5, 2021 by The Health Master

BENGALURU: To shorten the duration of treatment for drug-resistant TB patients (DRTB), the health department has launched an injectable-free Bedaquiline regimen.

Usually, DRTB patients do not respond to normal treatment of 3-4 injections daily.

“The regular medicines are given for 9 to 24 months. However, Bedaquiline is given only for 9 to 12 months.

There are various kinds of drug-resistant TB patients and in Karnataka, the number is 3,000. Of these, 1,000 are Rifampicin (antibiotic) resistant. These patients will be administered Bedaquiline,” said Dr Ramesh Reddy, joint director, Tuberculosis.

A culture test is done to know which drug the person is resistant to. There are around 500 patients in the state who are resistant to multiple drugs.

The initiative was launched on Monday by Dr Arundathi Chandrasekhar, director, National Health Mission, and is a step towards Kshaya Muktha (TB-free) Karnataka, the health department said.

Report of Govt Analyst and CDL must give factual data (Part-2)

FAQs on New Drug, Banned drugs etc.

Webinar held on Drafting of Complaints for Drug regulators of India

FDA grants permission to Mfr Amphotericin B to these Companies

Glenmark inks deal for COVID treatment Nasal Spray in India

Rotavac 5D receives WHO prequalification: Bharat Biotech

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner